2-178717960-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_001267550.2(TTN):c.25046C>G(p.Ala8349Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000036 in 1,612,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.25046C>G | p.Ala8349Gly | missense_variant | Exon 86 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.25046C>G | p.Ala8349Gly | missense_variant | Exon 86 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248226Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134626
GnomAD4 exome AF: 0.0000377 AC: 55AN: 1460280Hom.: 0 Cov.: 35 AF XY: 0.0000344 AC XY: 25AN XY: 726150
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Ala7105Gly variant in TTN has not been previously reported, but has been det ected in 1 individual with DCM tested by our laboratory. Computational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIF T) do not provide strong support for or against an impact to the protein. Compu tational tools predict that this variant may affect splicing, but additional stu dies are needed to further investigate this. In summary, additional information is needed to fully assess the clinical significance of the Ala7105Gly variant. -
not provided Uncertain:1
The A8032G variant of uncertain significance in the TTN gene has not been published as a pathogenic or benignvariant to our knowledge. The A8032G variant is not observed at a significant frequency in large population cohorts(Lek et al., 2016). This variant could be functionally significant at the mRNA or protein level. At the mRNA level,several in silico splicing models predict that this variant probably affects splicing by creating a strong cryptic donorsite upstream of the natural donor site for intron 84. However, in the absence of functional mRNA studies, thephysiological consequence of this variant cannot be determined. At the protein level, the A8032G variant is aconservative amino acid substitution that occurs at a position that is not conserved across species. In silico analysis isinconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at